CONSTANCE

Research CONSTANCE (CCR.WA) on Bullrun: market cap PLN 6.68M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is PLN 6.68M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025n/a-PLN 923.02Kn/an/a-1.17PLN 797PLN 13.90M-PLN 3.53M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-10PLN 6.68Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 PLN.

About CONSTANCE

Constance Care Spolka Akcyjna operates a center for neurological, orthopedic, and neuropsychological rehabilitation. The company offers functional therapies, including neurological, orthopedic, robotic, cellular, sensory, post-stroke, post-accident, post-injury/fracture, post-surgery/joint replacement, and post-spinal cord injury rehabilitation programs, as well as gait re-education. It offers its programs under the NEURO Premium, NEURO Premium MAX, Post-Stroke, ORTO Premium MAX, and Post-Joint Replacement names.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is CONSTANCE's market cap?

CONSTANCE's market capitalization is PLN 6.68M.

What does CONSTANCE do?

Constance Care Spolka Akcyjna operates a center for neurological, orthopedic, and neuropsychological rehabilitation. The company offers functional therapies, including neurological, orthopedic, robotic, cellular, sensory, post-stroke, post-accident, post-injury/fracture, post-surgery/joint replacement, and post-spinal cord injury rehabilitation programs, as well as gait re-education. It offers its programs under the NEURO Premium, NEURO Premium MAX, Post-Stroke, ORTO Premium MAX, and Post-Joint Replacement names.